Drugs / ALY688
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04201574 | Dec 2019 → Sep 2020 | dry eye syndrome | Allysta Pharmaceutical | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04899518 | May 2021 → Mar 2023 | dry eye syndrome | Allysta Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ALY688 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04201574 ↗ |